Description  Claims  Drawing  Cited references 

US1425673W   [0042]  [0120] 
WO2014160030A   [0042] 
US62275600B   [0125] 

GENE THERAPY   [0003] 
concerns a pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response   [0004] 
concerns combination immunotherapy with NY-ESO-1-specific CAR+ T cells with T-cell vaccine improves anti-myeloma effect   [0005] 
Gene Transfer: Delivery and Expression of DNA and RNA, A Laboratory Manual   [0035] 
Cancer Research   [0036] 
Molecular Therapy-Nucleic Acids   [0036] 
Cancer Immunology, Immunotherapy   [0039]